Catalysts for Aurobindo Pharma USA Inc
69 tracked
Apr 15, 2026
drug shortage
Quinapril Hydrochloride Tablet shortage — Aurobindo Pharma USA
Aurobindo Pharma USA Inc
→
Apr 15, 2026
drug shortage
Quinapril/Hydrochlorothiazide Tablet shortage — Aurobindo Pharma USA
Aurobindo Pharma USA Inc
→
Apr 15, 2026
drug shortage
Clonazepam Tablet shortage — Aurobindo Pharma USA
Aurobindo Pharma USA Inc
→
Apr 15, 2026
drug shortage
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage — Aurobindo Pharma USA
Aurobindo Pharma USA Inc
→
Apr 6, 2026
approval
PAROXETINE HYDROCHLORIDE — FDA approval
PAROXETINE HYDROCHLORIDE
→
Apr 6, 2026
approval
PAROXETINE HYDROCHLORIDE — FDA approval
PAROXETINE HYDROCHLORIDE
→
Apr 6, 2026
approval
PAROXETINE HYDROCHLORIDE — FDA approval
PAROXETINE HYDROCHLORIDE
→
Apr 6, 2026
approval
PAROXETINE HYDROCHLORIDE — FDA approval
PAROXETINE HYDROCHLORIDE
→
Dec 31, 2025
approval
DICLOFENAC SODIUM — FDA approval
DICLOFENAC SODIUM
→
Nov 5, 2025
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Nov 5, 2025
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Jun 25, 2025
recall
Aurobindo Pharma USA Inc recall (Cls II)
Aurobindo Pharma USA Inc
→
Mar 13, 2025
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Feb 12, 2025
recall
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recall (Cls II)
Aurobindo Pharma USA Inc
→
Dec 25, 2024
recall
Aurobindo Pharma USA Inc recall (Cls II)
Aurobindo Pharma USA Inc
→
Dec 11, 2024
recall
Aurobindo Pharma USA Inc recall (Cls II)
Aurobindo Pharma USA Inc
→
Dec 11, 2024
recall
Aurobindo Pharma USA Inc recall (Cls II)
Aurobindo Pharma USA Inc
→
Dec 11, 2024
recall
Aurobindo Pharma USA Inc recall (Cls II)
Aurobindo Pharma USA Inc
→
Nov 21, 2024
approval
DICLOFENAC SODIUM — FDA approval
DICLOFENAC SODIUM
→
May 7, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Oct 18, 2022
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Oct 18, 2022
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Oct 18, 2022
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Oct 18, 2022
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Oct 18, 2022
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
May 4, 2021
approval
PAROXETINE HYDROCHLORIDE — FDA approval
PAROXETINE HYDROCHLORIDE
→
May 4, 2021
approval
PAROXETINE HYDROCHLORIDE — FDA approval
PAROXETINE HYDROCHLORIDE
→
May 4, 2021
approval
PAROXETINE HYDROCHLORIDE — FDA approval
PAROXETINE HYDROCHLORIDE
→
May 4, 2021
approval
PAROXETINE HYDROCHLORIDE — FDA approval
PAROXETINE HYDROCHLORIDE
→
Apr 28, 2021
approval
DICLOFENAC SODIUM — FDA approval
DICLOFENAC SODIUM
→